By Marion Renault and Marshall Ritzel

Almost six months after a rare face and hands transplant, Joe DiMeo is relearning how to smile, blink, pinch and squeeze.

The 22-year-old New Jersey resident had the operation last August, two years after being badly burned in a car crash.

“I knew it would be baby steps all the way,” DiMeo told The Associated Press. “You’ve got to have a lot of motivation, a lot of patience. And you’ve got to stay strong through everything.”

Experts say it appears the surgery at NYU Langone Health was a success, but warn it’ll take some time to say for sure.

Worldwide, surgeons have completed at least 18 face transplants and 35 hand transplants, according to the United Network for Organ Sharing, or UNOS, which oversees the U.S. transplant system.

But simultaneous face and double hand transplants are extremely rare and have only been tried twice before. The first attempt was in 2009 on a patient in Paris who died about a month later from complications. Two years later, Boston doctors tried it again on a woman who was mauled by a chimpanzee, but ultimately had to remove the transplanted hands days later.

“The fact they could pull it off is phenomenal,” said Dr. Bohdan Pomahac, a surgeon at Boston’s Brigham and Women’s Hospital who led the second such attempt. “I know firsthand it’s incredibly complicated. It’s a tremendous success.”

DiMeo will be on lifelong medications to avoid rejecting the transplants, as well as continued rehabilitation to gain sensation and function in his new face and hands.

In 2018, DiMeo fell asleep at the wheel, he said, after working a night shift as a product tester for a drug company. The car hit a curb and utility pole, flipped over, and burst into flames. Another driver who saw the accident pulled over to rescue DiMeo.

Afterward, he spent months in a medically induced coma and underwent 20 reconstructive surgeries and multiple skin grafts to treat his extensive third-degree burns.

Once it became clear conventional surgeries could not help him regain full vision or use of his hands, DiMeo’s medical team began preparing for the risky transplant in early 2019.

“Within the world of transplantation, they’re probably the most unusual,” said Dr. David Klassen, UNOS chief medical officer.

Almost immediately, the NYU team encountered challenges including finding a donor.

Doctors estimated he only had a 6% chance of finding a match compatible with his immune system. They also wanted to find someone with the same gender, skin tone and hand dominance.

Then during the search for a donor, the pandemic hit and organ donations plummeted. During New York City’s surge, members of the transplant unit were reassigned to work in COVID-19 wards.

In early August, the team finally identified a donor in Delaware and completed the 23-hour procedure a few days later.

They amputated both of DiMeo’s hands, replacing them mid-forearm and connecting nerves, blood vessels and 21 tendons with hair-thin sutures. They also transplanted a full face, including the forehead, eyebrows, nose, eyelids, lips, both ears and underlying facial bones.

“The possibility of us being successful based on the track record looked slim,” said Dr. Eduardo Rodriguez, who led the medical team of more than 140 people. “It’s not that someone has done this many times before and we have a kind of a schedule, a recipe to follow.”

So far, DiMeo has not shown any signs of rejecting his new face or hands, said Rodriguez, who revealed details of the transplant Wednesday.

Since leaving the hospital in November, DiMeo has been in intensive rehabilitation, devoting hours daily to physical, occupational and speech therapy.

“Rehab was pretty intense,” DiMeo said, and involves a lot of “retraining yourself to do stuff on your own again.”

During a recent session, he practiced raising his eyebrows, opening and closing his eyes, puckering his mouth, giving a thumbs up and whistling. DiMeo can feel his new forehead and hands get cold, and often reaches up to push his long hair off of his face.

DiMeo, who lives with his parents, can now dress and feed himself. He shoots pool and plays with his dog Buster. Once an avid gym-goer, DiMeo is also working out again — benching 50 pounds and practicing his golf swing.

“You got a new chance at life. You really can’t give up," he said.

As with any transplant, the danger of rejection is highest early on, but lasts indefinitely. The medications he takes also leave him vulnerable, for the rest of his life, to infections.

“You’re never free from that risk,” Klassen said. “Transplantation for any patient is a process that plays out over a long period of time.”

Still, Rodriguez said he’s amazed to see that DiMeo has been able to master skills like zipping up his jacket and putting on his shoes.

“It’s very gratifying to all of us,” Rodriguez said. “There’s a tremendous sense of pride.”

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
This Year In Trivia
Hena Doba and Azia Celestino recap some of the biggest stories of the year, and learn a thing or two while they're at it. It's This Year in Trivia!
COVID-19 May Soon Lose 'Pandemic' Status, Becoming Endemic
Experts say that at some point next year, the pandemic will officially drop its pandemic status, becoming endemic. While this is a milestone to acknowledge, it does not mean we're free of infections, illnesses, and deaths. Dr. Rajeev Fernando, infectious disease specialist, Beth Israel Hospital and fellow, joins Cheddar News' Closing Bell to discuss.
Experts Warn Pfizer, Merck COVID-19 Treatments Need Careful Supervision
Dr. Soumi Eachempati, co-founder and CEO of Cleared4 and former professor of surgery and public health at Weill Cornell Medical College, joined Cheddar to breakdown what people should know about the recently FDA-approved emergency use of Merck and Pfizer's COVID-19 treatment pills. He noted that not only do people need to be aware of other medications they are taking that could cause adverse effects if coupled with COVID-19 pill treatments, he also talked about the intense in-take regiment. "The Merck pills are actually about 40 pills over five days. The Pfizer ones are three pills over five days, so people have to be prepared for that because it is a lot of pills you'll have to take to get full value from these drugs," Eachempati told Cheddar.
Is the 'CDC Says...' Meme More than Lighthearted Jokes?
Twitter is exploding with a new meme after the CDC revised its Covid-19 guidelines, shortening the recommended isolation period to five days instead of 10 for when you test positive and are asymptomatic. The change came amid a skyrocketing surge of new cases is the U.S. due to the Omicron variant, drawing criticism from experts and Twitter --with users claiming the government agency is giving funny advise on a variety of issues. But what does the meme say about the public’s trust in the agency? Cheddar News speaks with political strategist Hastie Afkhami.
U.S.Government Falling Short on 'Genomic Surveillance' and Testing
The list of questions should be getting shorter as we enter the pandemic's third year, but that isn't the case. There's another question to add to that list: is the U.S. doing enough to track the virus and its variants? Lawrence Gostin, faculty director of the O'Neill Institute for national and global health law at Georgetown University, joins Cheddar News.
Rethink Your New Year's Eve Plans with Rising COVID-19 Cases
As we prepare to ring in the new year, COVID cases are hitting an all-time high. Dr. Anthony Fauci has said the safest way to celebrate would be a small gathering with vaccinated family members only... far from the large, flashy parties from a few years ago. Dr. Christina Johns, senior medical advisor at PM Pediatrics, joins Cheddar News to discuss how to celebrate safely.
Load More